Abstract: Th ough Americans make 1.8 million asthma-related outpatient visits to the emergency department (ED) annually, little is known about the episodic charges for asthma care in the ED. We therefore sought to assess the bills patients could face for acute asthma incidents by examining hospital charges for asthma-related outpatient ED visits. We performed a nationwide, cross-sectional study of 2.9 million weighted asthma-related outpatient ED visits from 2006-2008 using data from the Medical Expenditure Panel Survey. We found that the average charge for an outpatient ED visit was $1,502 (95% CI $1,493-$1,511). Th e charges did not vary signifi cantly by insurance group but did increase signifi cantly with age. Our results indicate that the fi nancial burden of ED care for asthma may take a severe toll on low-income populations who have limited ability to pay, especially patients who must pay undiscounted charges, including the uninsured and those on high-deductible health plans.
addition, low-income Medicaid patients disproportionately seek care in the ED, 13 and increasingly could face unaff ordable and burdensome co-pays and cost sharing as part of their care. [14] [15] [16] Previous work by our team has explored charges for the top ten ED diagnoses among non-elderly adults, but has not addressed charges for asthma. 17 Due to the disproportionate health care use for asthma by low-income patients, 5 who are oft en uninsured and have limited ability to pay, we felt that charges for ED treatment of asthma were particularly relevant for patients and policymakers. In addition, though asthma patients are signifi cantly more likely to receive outpatient care in the ED than be admitted to the hospital, 12, 18 past studies of the cost burden of hospital visits for asthma patients have focused on inpatient care. [19] [20] [21] [22] As emergency department charges rise, 23 and patients are responsible for a greater portion of their health care costs, 24 understanding the cost of this ED care for asthma is increasingly important to patients. Further, emergency physicians oft en struggle to respond to inquiries from patients about the charges of their care 25 and should have information available as to an asthma patient's likely charges. In this study, we sought to assess the fi nancial burden of acute asthma exacerbations by analyzing the charges facing patients who visit the ED as an outpatient for asthma-related complications. Specifi cally, we attempted to determine whether these charges vary by insurance status, as diff erent charges have unique consequences for these demographics.
Methods
We performed a nationwide, cross-sectional study of outpatient asthma-related ED visits from 2006-2008. Data on visits, charges and insurance status were obtained from the Medical Expenditure Panel Survey (MEPS) conducted by the Agency for Health care Research and Quality. Th e MEPS is a large-scale national survey that incorporates a Household Component gathered from a sample of patients and households who are representative of the U.S. civilian non-institutionalized population. 26 An additional Medical Provider Component consists of data provided by pharmacies and medical providers to supplement and verify information from the household sample. 27 Specifically, the Emergency Room Visits portion of the Medical Provider Component collects information on each reported visit, including diagnosis and procedure codes, charges, and payments.
Study design and data sources. To create a database of ED visits, we linked the MEPS Emergency Room Visits data fi le (patient conditions, charges, expenditures, and payments) with the MEPS Full Year Consolidated data fi le (patient demographic and insurance information). In accordance with previous studies using MEPS, 28 our sample consisted of all outpatient ED visits that had asthma recorded as one of the top three patient conditions (International Classifi cation of Diseases, 9th Edition [ICD-9] code 493). We focused on outpatient ED visits so that our data would not be aff ected by hospitalization expenses or severe comorbidities that would drive up charges. In our stratifi ed analysis, we defi ned four categories for patient insurance: uninsured, Medicare, Medicaid, and private insurance. Th e insurance status variables indicated whether a patient had a particular form of insurance at any time during the year of the ED visit.
Th is study was exempt from review by the UCSF Institutional Review Board. Outcome measure. Our primary outcome measure was total charges: the dollar amount seen on a patient's hospital bill, to be paid either by the patient or their insurance.
Statistical analysis. Initially, we compared the demographics of our sample including race, income, region, gender, and age between diff erent insurance groups using a chisquare test of independence. We then descriptively analyzed the charges by insurance group, using ANOVA to compare means between the groups. Charges were adjusted to 2008 USD due to substantial changes in the Bureau of Labor Statistics' Consumer Price Index from 2006 to 2008. 29 For population-level estimates, the data were weighted according to the appropriate sampling weights for the 2006-2008 MEPS surveys. 30 We further stratifi ed these insurance-specifi c charges by age group (0-19 years, 20-44 years, 45-64 years, and 65 years or older) as is commonly done in the literature on medical charges and spending 31, 32 in order to provide estimates with less variability due to comorbidities, severity, and clinical outcomes. 26, 27 Finally, we ran a linear regression model using log-transformed charges as our dependent variable to control for charge's rightward skew. We regressed age on these charges and used fi xed eff ects for insurance to calculate predicted prices for each insurance type at diff erent ages. We further controlled for region, patient income, race, and gender.
Results
Th e fi nal weighted sample consisted of 2.9 million asthma-related ED visits from 2006-2008. As shown in Table 1 , the majority of the sample was non-white (77%) and low income (≤ 200% of the federal poverty line [FPL]) (56%). Twenty percent of patients had no insurance, Medicaid covered 39%, 19% had Medicare, and 46% were privately insured. Low-income patients (≤ 200% FPL) comprised 69% of those with no insurance, 87% of Medicaid patients, 66% of Medicare patients, and 24% of the privately insured.
Th e charges incurred for asthma-related ED visits ranged from $19 to $12,601, averaging $1,502 per visit (95% CI 1493-1511). Table 2 shows charges by age and insurance status. Medicare patients had the highest mean charge at $2,211 per visit (95% CI: $1619-$2803), followed by the privately insured ($1,767; 95% CI: $1478-$2055). Uninsured ($1,463; 95% CI: $1075-$1851) and Medicaid patients ($1,450; 95% CI: $1221-$1678) had lower charges. Upon analysis of the stratifi ed charges using ANOVA, we could not reject the possibility that all of the insurance group means were the same.
Our linear model indicated that predicted charges for outpatient asthma-related ED visits increased signifi cantly with age across all insurance groups, as shown in Figure 1 .
Discussion
Our results indicate that in the United States, patients will be charged an average of $1,502 for an outpatient ED visit for asthma. Th e variability is large, however, as charges can range from $19 to $12,601. Th ese costs of visiting the ED can also be multiplicative, as visits are common among patients with chronic asthma. 33 Th ese charges pose a signifi cant hardship to asthma patients who are uninsured or who have high deductible health plans, as they are responsible for all or most of this charge each time they visit. Note the insurance-specifi c samples may sum to more than the total sample, as insurance categories are not mutually exclusive. Th ese groups encompass an increasing portion of patients, because though the number of uninsured Americans has leveled at 16%, 34 the proportion of people with employersponsored insurance plans with deductibles over $1,000 for single coverage ($2,000 for family coverage) has increased from 4% in 2006 to 19% in 2012. 24 Past literature has shown that high-deductible plans can result in signifi cant fi nancial burden for families with members who have chronic diseases such as asthma. [35] [36] [37] Further, the low-income patients in our sample constituted 69% of the uninsured and 24% of the privately insured. Th ese patients likely represent the working poor, who are charged a signifi cant amount for asthma care but who have a limited ability to pay. For instance, a $1,502 charge for a single person at 200% of the FPL would represent 7% of their annual income in 2008. 38 Th is is of particular concern because asthma disproportionately aff ects low-income populations. 7 In fact, low-income families and those who are on high-deductible plans have been shown to forego or delay care because of cost and to feel as if they had little control over costs in clinical encounters. 39, 40 Th e burden of these charges can be mitigated by hospitals' charity care provided to very-low-income patients without insurance. 41, 42 However, this practice is limited to the poorest patients and cannot be guaranteed upon arrival. 42 Even if patients end up paying only a portion of their charges, the fi nancial repercussions for middle or lower-income families are oft en still severe.
Th e variability in possible charges poses additional challenges to any patient attempting to control their health care costs for asthma. Not knowing and not being able to determine cost of care for an episode of asthma can discourage care-seeking and burden those who come to the ED with an urgent asthma exacerbation and thus do not have the ability to spend time determining the lowest-cost location. 40, 43 Th ough this variability makes it hard for physicians to estimate a patient's charges for asthma upon inquiry, knowledge of this variability can be shared with patients to prepare them for the large range in possible bills they could face.
Consistent with previous studies, our results indicated an increase in ED charges with increasing age. 5, 44 Th is was expected due to age-associated comorbidities such as chronic obstructive pulmonary disease that are likely to complicate disease management and thus increase charges. 45, 46 Interestingly, charges did not vary signifi cantly by insurance coverage. Th is trend may be a consequence of hospital charge masters, which provide common charges for billing of all patients. Th ese charge masters oft en list infl ated prices in anticipation of negotiated discounts with insurance companies. 47, 48 Even if Medicare, which had the highest mean charge of the insurance groups, however, did have a statistically signifi cant higher charge, it would not be surprising given that Medicare patients are older and, on the whole, sicker than patients in other insurance groups and may require more intensive care, even if discharged.
Limitations. Th is study had several limitations associated with the nature of the MEPS survey. First, patient report of whether they were insured under a particular plan at any point during the year served as a crude measure of insurance status at the time of the ED visit. It is plausible that a patient who reported being uninsured was in fact insured during the asthma-related ED visit. However cross-classifi cation by insurance status and payment source in our analysis indicated few discrepancies between the two variables. For example, one would expect patients insured by Medicare and Medicaid to have very few out-of-pocket payments if they were in fact insured by Medicare and Medicaid for most of the year. Our data did in fact show that these patients had few out-of-pocket payments, suggesting that the health insurance variable in the MEPS survey oft en corresponded to insurance status at the time of visit.
Second, the data from MEPS used in this study largely rely on direct survey of patients, which may be inaccurate. However, these limitations are addressed in part by the Medical Provider Component, which validates household reporting of medical use and expenditures. Furthermore, we think the use of MEPS is still suitable in our analysis due to its utilization in previous studies that considered variables similar to those used in this study in order to analyze trends in asthma 28, 49 and other conditions. 50, 51 Another potential limitation is that patients who have respiratory conditions other than asthma may have more complications or require more treatment in the ED and as a result, incur higher charges. We address this concern by limiting our analysis to visits that were discharged from the ED so that visits with severe comorbidities leading to hospitalization are not included in the analysis. Furthermore, we conducted analyses by age group, which is closely associated with comorbidities. Charge variations among patients of diff erent insurance status even within age groups suggested that disparities in charges extend beyond more expensive management for patients with comorbidities.
Conclusions. On average, a patient visiting the ED as an outpatient will be charged $1,502 for treatment of asthma, though recorded charges varied from $19 to $12,601. Uninsured patients and those on high-deductible private health plans are especially aff ected by these charges, and low-income patients who are disproportionately aff ected by asthma face signifi cant challenges to paying such an ED bill. Further research is warranted on the sources of variability in ED charges for asthma patients and their impact on the fi nances and health of patients with asthma.
